Share updated Phase 1b data for DISC-0974 in NDD-CKD
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 8 Aug 2024
- Due
- 31 Dec 2024
- Delivered
- October 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Updated Phase 1b data from DISC-0974 in anemia in non-dialysis-dependent chronic kidney disease (NDD-CKD) is expected to be shared in the second half of 2024”
What we found
Evidence strength A What the grades mean
The company confirmed in multiple SEC filings that it announced initial data from the Phase 1b DISC-0974 trial in patients with anemia and NDD-CKD in October 2024, which falls within the second half of 2024.
-
A Disc Medicine, Inc. 10-K filed 2025-02-27
“we announced initial data from our Phase 1b/2 DISC-0974 trial in patients with anemia of MF in December 2023, June 2024, and December 2024, and from our Phase 1b DISC-0974 trial in patients with anemia and NDD-CKD in December 2023 and October 2024.” ✓ confirmed on the page
Market reaction: the shares moved +1.6% against the S&P 500 over the three sessions around the disclosure (26 Feb 2025 to 3 Mar 2025). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Share
- Deliverable
- Phase 1b data
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Disc Medicine, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-IRON-002170 · Corrections policy